[{"indications": "Indications\u00a0see preparations", "name": "MICONAZOLE Buccal preparation", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.3 Drugs acting on the oropharynx", "12.3.2 Oropharyngeal anti-infective drugs", "Oropharyngeal fungal infections", "MICONAZOLE", "Buccal preparation"], "cautions": "Cautions\u00a0avoid in acute porphyria (section 9.8.2); interactions: Appendix 1\r\n(antifungals, imidazole)", "side-effects": "Side-effects\u00a0nausea, vomiting; rash; with buccal tablets, abdominal pain, taste disturbance, burning sensation at application\r\nsite, pruritus, and oedema; with oral gel, very rarely diarrhoea (usually on long-term treatment),\r\nhepatitis, toxic epidermal necrolysis, and Stevens-Johnson syndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200949.htm", "doses": ["See preparations", "Name[Loramyc\u00ae (Therabel) ] Mucoadhesive buccal tablets, white-yellow,\r\nmiconazole 50\u00a0mg, net price 14-tab pack = \u00a352.12. \r\n    Label:\r\n    10, counselling, administrationDose\u00a0oropharyngeal candidiasis in immunocompromised adult, 50\u00a0mg daily preferably taken in the morning\r\nfor 7 days; if no improvement, continue treatment for a further 7\r\ndaysCounselling\u00a0Place rounded side of tablet on upper\r\ngum above an incisor tooth and hold upper lip firmly over the gum\r\nfor 30 seconds using a finger. If tablet detaches within 6 hours,\r\nreplace with a new tablet. With each dose, use alternate sides of\r\nthe gumNote\u00a0 The Scottish Medicines Consortium  has advised (January 2011) that miconazole mucoadhesive buccal tablets\r\n(Loramyc\u00ae) are not recommended for use within NHS\r\nScotland."], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid if possible\u2014toxicity at\r\nhigh doses in animal studies"}, {"indications": "Indications\u00a0see preparations", "name": "MICONAZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.3 Drugs acting on the oropharynx", "12.3.2 Oropharyngeal anti-infective drugs", "Oropharyngeal fungal infections", "MICONAZOLE"], "cautions": "Cautions\u00a0avoid in acute porphyria (section 9.8.2); interactions: Appendix 1\r\n(antifungals, imidazole)", "side-effects": "Side-effects\u00a0nausea, vomiting; rash; with buccal tablets, abdominal pain, taste disturbance, burning sensation at application\r\nsite, pruritus, and oedema; with oral gel, very rarely diarrhoea (usually on long-term treatment),\r\nhepatitis, toxic epidermal necrolysis, and Stevens-Johnson syndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200948.htm", "doses": ["See preparations"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid if possible\u2014toxicity at\r\nhigh doses in animal studies"}, {"indications": "Indications\u00a0fungal skin infections; oral and intestinal fungal\r\ninfections (section 12.3.2); vaginal candidiasis (section 7.2.2)", "name": "MICONAZOLE NITRATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.10 Anti-infective skin preparations", "13.10.2 Antifungal preparations"], "cautions": "Cautions\u00a0\n(From 13.10.2 Antifungal preparations: British National Formulary)\nCautions\u00a0Contact with eyes and mucous membranes should be avoided.; interactions:\r\nAppendix 1 (miconazole)", "side-effects": "Side-effects\u00a0see notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6163.htm", "doses": ["Apply twice daily continuing for 10 days after lesions\r\nhave healed; nail infections, apply 1\u20132 times daily"]}]